Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.

Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.

Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphoblastic leukemia (T-ALL), including early T-cell precursor ALL (ETP-ALL) cases with poor prognosis. Lmo2 must be recruited to DNA by binding to the hematopoietic basic helix-loop-helix factors Scl/Tal1 o...

Bibliografski detalji
Glavni autori:	McCormack, M, Shields, B, Jackson, J, Nasa, C, Shi, W, Slater, N, Tremblay, C, Rabbitts, T, Curtis, D
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
od: McCormack, M, i dr.
Izdano: (2004)

The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
od: McCormack, M, i dr.
Izdano: (2010)

Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements
od: Irene Homminga, i dr.
Izdano: (2012-02-01)

Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
od: Virginie Deleuze, i dr.
Izdano: (2012-01-01)

The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
od: McCormack, M, i dr.
Izdano: (2003)

50 números de LyL
od: Javier González Riffo
Izdano: (2024-10-01)

Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
od: Tse, E, i dr.
Izdano: (2004)

The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
od: Nam, C, i dr.
Izdano: (2006)

LMO2 at 25 years: a paradigm of chromosomal translocation proteins
od: Jennifer Chambers, i dr.
Izdano: (2015-01-01)

Lyl-1 regulates primitive macrophages and microglia development
od: Shoutang Wang, i dr.
Izdano: (2021-12-01)

T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.
od: Drynan, L, i dr.
Izdano: (2001)

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.
od: Nam, C, i dr.
Izdano: (2008)

The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
od: Yamada, Y, i dr.
Izdano: (2000)

Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
od: Appert, A, i dr.
Izdano: (2009)

The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
od: Yamada, Y, i dr.
Izdano: (2002)

The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis
od: Yoshihiro Yamada, i dr.
Izdano: (2022-05-01)

Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex
od: Sewell, H, i dr.
Izdano: (2014)

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
od: Gering, M, i dr.
Izdano: (2003)

APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL
od: Li, Z, i dr.
Izdano: (2018)

SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
od: Bastien Gerby, i dr.
Izdano: (2014-12-01)

Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.
od: Tanaka, T, i dr.
Izdano: (2011)

Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence
od: Mehdi Heidari Horestani, i dr.
Izdano: (2024-12-01)

LMO2 and gene therapy for severe combined immunodeficiency.
od: Fischer, A, i dr.
Izdano: (2004)

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
od: Ruggero, K, i dr.
Izdano: (2016)

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
od: Ruggero, K, i dr.
Izdano: (2016)

Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice
od: Shelby-Sara Jones, i dr.
Izdano: (2022-09-01)

Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model
od: Pais, H, i dr.
Izdano: (2019)

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms
od: Steven Goossens, i dr.
Izdano: (2019-08-01)

LYL1 degradation by the proteasome is directed by a N-terminal PEST rich site in a phosphorylation-independent manner.
od: Georgi L Lukov, i dr.
Izdano: (2010-09-01)

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
od: Hacein-Bey-Abina, S, i dr.
Izdano: (2003)

Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.
od: El Omari, K, i dr.
Izdano: (2013)

Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) Gene Expression in Egyptian Patients with Acute Myeloid Leukemia
od: Nadia El Menshawy, i dr.
Izdano: (2014-05-01)

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
od: Fang Fang, i dr.
Izdano: (2022-07-01)

Structural Basis for LMO2-Driven Recruitment of the SCL: E47bHLH Heterodimer to Hematopoietic-Specific Transcriptional Targets
od: ElOmari, K, i dr.
Izdano: (2013)

Expression of Lmo2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma
od: Božo Krušlin, i dr.
Izdano: (2018-01-01)

Effectiveness of local microorganisms (LMO) coconut pulp on composting time
od: Darwel, i dr.
Izdano: (2021-06-01)

Lmo4 in the basolateral complex of the amygdala modulates fear learning.
od: Rajani Maiya, i dr.
Izdano: (2012-01-01)

LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data
od: Se Ik Kim, i dr.
Izdano: (2018-05-01)

The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
od: Patterson, L, i dr.
Izdano: (2007)

Structural Basis for LMO2-Driven Recruitment of the SCL:E47bHLH Heterodimer to Hematopoietic-Specific Transcriptional Targets
od: Kamel El Omari, i dr.
Izdano: (2013-07-01)